India  

Blood pressure medications safe for COVID-19 patients: Study

Video Credit: ANI - Duration: 01:10s - Published
Blood pressure medications safe for COVID-19 patients: Study

Blood pressure medications safe for COVID-19 patients: Study

An international team of researchers have found that medications to treat high blood pressure do not affect outcomes among patients hospitalized with COVID-19.

The study, led by researchers from Perelman School of Medicine at the University of Pennsylvania, published today in The Lancet Respiratory Medicine, is the first randomized controlled trial to show there is no risk for patients continuing these medications while hospitalized for COVID-19.

More than 49 million U.S. adults take medication to treat hypertension, and among those, about 83 percent (41 million) take an ACEI or ARB, according to the Centers for Disease Control and Prevention.

Early during the pandemic, a concern arose regarding the use of ACEIs or ARBs in the setting of COVID-19, since some studies had suggested that these medications could upregulate cellular receptors for the SARS-CoV-2 virus potentially aiding viral replication.

However, it was also considered that some effects of these medications could be protective against the virus.

ACEIs and ARBs are among the most commonly prescribed medications in the world, and a potential link between those medications and COVID-19 outcomes has large global health implications, the authors say.

Several observational studies suggested no association between outpatient ACEI or ARB use and risk of COVID-19 hospitalization, but high-quality randomized trial evidence was lacking, until now.

Currently, trials are underway to determine if the use of these medications is effective for the treatment of COVID-19.


You Might Like


๐Ÿ’ก newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis [Video]

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis

A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccineโ€™s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research. #IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity ~HT.97~PR.152~

Credit: Oneindia    Duration: 03:29Published

Related videos from verified sources

High omega-3 index people less likely to die from COVID-19: Study [Video]

High omega-3 index people less likely to die from COVID-19: Study

A recent study suggested that people who have a higher omega-3 index have a lower probability of dying due to COVID-19.Researchers with the Fatty Acid Research Institute (FARI) and collaborators at..

Credit: ANI     Duration: 01:22Published
New study explains how SARS-CoV-2 may seize human cells [Video]

New study explains how SARS-CoV-2 may seize human cells

Another detailed study by the American Association for the Advancement of Science asserts that the SARS-CoV-2 virus not only targets to enter the human cells but begin to replicate and spread as well...

Credit: ANI     Duration: 01:10Published
UM Conducts Study On Impact Of High-Blood Pressure Medications On COVID Patients [Video]

UM Conducts Study On Impact Of High-Blood Pressure Medications On COVID Patients

As Floridians flock to COVID vaccine sites in the rush to get vaccinated, many who are dealing with high blood pressure have questions about their medications and how these might impact their recovery..

Credit: CBS4 Miami     Duration: 01:56Published